New directions in poly(ADP-ribose) polymerase biology

被引:61
|
作者
Bock, Florian J. [1 ,2 ]
Chang, Paul [3 ]
机构
[1] Canc Res UK Beatson Inst, Garscube Estate, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Canc Sci, Garscube Estate, Glasgow, Lanark, Scotland
[3] Ribon Therapeut, Lexington, MA 02421 USA
关键词
ADP-ribosylation; poly(ADP-ribose) polymerases; post-translational modification; stress response; NF-KAPPA-B; ADP-RIBOSYLTRANSFERASE ARTD10; PROTEOME-WIDE IDENTIFICATION; DNA STRAND BREAKS; RNA REGULATION; STRESS RESPONSES; MAMMALIAN-CELLS; ES CELLS; T-CELLS; RIBOSE;
D O I
10.1111/febs.13737
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ADP-ribose) polymerases (PARPs) regulate the function of target proteins by modifying them with ADP-ribose, a large and unique post-translational modification. Humans express 17 PARPs; however, historically, much of the focus has been on PARP1 and its function in DNA damage repair. Recent work has uncovered an amazing diversity of function for these enzymes including the regulation of fundamental physiological processes in the cell and at the organismal level, as well as new roles in regulating cellular stress responses. In this review, we discuss recent advancements in our understanding of this important protein family, and technological developments that have been critical for moving the field forward. Finally, we discuss new directions that we feel are important areas of further scientific exploration.
引用
收藏
页码:4017 / 4031
页数:15
相关论文
共 50 条
  • [41] Functions of the poly(ADP-ribose) polymerase superfamily in plants
    Rebecca S. Lamb
    Matteo Citarelli
    Sachin Teotia
    Cellular and Molecular Life Sciences, 2012, 69 : 175 - 189
  • [42] Poly(ADP-ribose)polymerase inhibition decreases angiogenesis
    Rajesh, Mohanraj
    Mukhopadhyay, Partha
    Godlewski, Grzegorz
    Batkai, Sandor
    Hasko, Gyorgy
    Liaudet, Lucas
    Pacher, Pal
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (04) : 1056 - 1062
  • [43] Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase
    Menear, Keith A.
    Adcock, Claire
    Alonso, Francisco Cuenca
    Blackburn, Kristel
    Copsey, Louise
    Drzewiecki, Jan
    Fundo, Alexandra
    Le Gall, Armelle
    Gomez, Sylvie
    Javaid, Hashim
    Lence, Carlos Fenandez
    Martin, Niall M. B.
    Mydlowski, Chris
    Smith, Graeme C. M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 3942 - 3945
  • [44] Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
    Smith, S
    Giriat, I
    Schmitt, A
    de Lange, T
    SCIENCE, 1998, 282 (5393) : 1484 - 1487
  • [45] POLY(ADP-RIBOSE) POLYMERASE - MOLECULAR BIOLOGICAL ASPECTS
    DEMURCIA, G
    MENISSIERDEMURCIA, J
    SCHREIBER, V
    BIOESSAYS, 1991, 13 (09) : 455 - 462
  • [46] Poly(ADP-ribose) polymerase inhibitors as cancer therapy
    Hilton, John F.
    Hadfield, Matthew J.
    Tran, Minh-Thu
    Shapiro, Geoffrey I.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1393 - 1407
  • [47] Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma
    Vormoor, Britta
    Curtin, Nicola J.
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (04) : 428 - 433
  • [48] Cleavage of poly(ADP-ribose) polymerase during apoptosis
    Soldani, C
    Lazzè, MC
    Bottone, MG
    Tognon, G
    Biggiogera, M
    Pellicciari, C
    Scovassi, AI
    PROCEEDINGS OF THE 5TH MULTINATIONAL CONGRESS ON ELECTRON MICROSCOPY, 2001, : 135 - 136
  • [49] Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy
    Miller, Rowan E.
    CANCER JOURNAL, 2021, 27 (06): : 506 - 510